Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations, SOR/2022-18

Section 13

Labelling

Cite as Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations, SOR/2022-18, s. 13 · current to July 24, 2025 · regulation last amended February 27, 2022

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) A person must not import or sell a medical device for which a COVID-19 medical device authorization has been issued or conduct a clinical trial in respect of such a device unless the device has a label that sets out the following information: (a) the name of the device; (b) the name and contact information of the manufacturer; (c) the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or device group family; (d) in the case of a Class III or IV device, the control number; (e) if the contents are not readily apparent, an indication of what the package contains, expressed in terms appropriate to the device, such as the size, net weight, length, volume or number of units; (f) a statement indicating that the device is sterile, if the device is to be sold in a sterile condition; (g) the expiry date of the device, if applicable; (h) the medical conditions, purposes and uses for which the device is manufactured, sold or represented, including its performance specifications if those specifications are necessary for proper use; (i) the directions for use, unless directions are not required for the device to be used safely and effectively; (j) any special storage conditions applicable to the device; (k) a statement indicating that the device is an investigational device; (l) a statement indicating that the device is to be used by qualified investigators only; and (m) in the case of an in vitro diagnostic device, a statement indicating that the performance specifications of the device have not been established. (2) The information required by subsection (1) to be set out on the label must be in English and in French.
Read the Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27; Patent Act, R.S.C. 1985, c. P-4.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.